Rating Change
Canaccord Genuity reiterated its Buy rating on CervoMed Inc. (NASDAQ:CRVO) on August 10, 2026.
reiterateNASDAQ:CRVO
Canaccord Genuity Reiterates Buy Rating on CervoMed Inc. (CRVO)
Canaccord Genuity reiterated its Buy rating on CervoMed Inc. (NASDAQ:CRVO) on August 10, 2026.
At publication ·
What changed
CervoMed Inc. (NASDAQ:CRVO) · reiterate
- Firm
- Canaccord Genuity
- Rating
- Buy to Buy
- Price at event
- $2.76
- Market capitalization
- $76.6M
At a glance
Key takeaways
- Canaccord Genuity reiterated a Buy rating on CervoMed Inc. (NASDAQ:CRVO) on August 10, 2026, with the stock trading at $2.76 and a market capitalization of $76.6 million.
Market Context
CervoMed Inc. operates in the Healthcare sector. The stock currently trades at $2.76 with a market capitalization of $76.6M. The stock has declined 70.4% over the past 52 weeks.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CervoMed Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CervoMed Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 10, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 13, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 09, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 23, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CRVO Stock Page
Frequently Asked Questions
What does the Buy rating mean for CRVO?
A rating of Buy from Canaccord Genuity reflects the analyst's outlook on CervoMed Inc. (NASDAQ:CRVO). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CRVO forecast page.